Global Quit Smoking Drugs Market
Pharmaceuticals

Emerging Trends and Growth Drivers in the Quit Smoking Drugs Market Through 2029

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Quit Smoking Drugs Market Expected to Be in 2029?

There has been swift expansion in the size of the quit smoking drugs market in the past few years. Its growth is projected to rise from $39.26 billion in 2024 to $44.23 billion in 2025, marking a compound annual growth rate (CAGR) of 12.7%. The significant growth witnessed during the historic period can be ascribed to factors such as health consciousness campaigns, advancements in medical science, government intervention, incorporation of behavioral therapies, and changes in consumer attitudes.

Forecasts predict a swift expansion in the market size of quit smoking drugs in the upcoming years, reaching $78.3 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 15.4%. The growth during the forecast period can be linked to factors such as investments in research and development, the rise in demand for cessation aids, specific marketing strategies, awareness programmes, and progress in pharmacotherapy. The major trends projected for this period involve customized treatment methods, a rise in health-conscious behavior, the use of digital therapeutics and applications, the inclusion of behavioral therapy, and targeted education and marketing.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9247&type=smp

What Are The Contributors To Demand In The Quit Smoking Drugs Market?

The escalating incidence of smoking addiction is projected to fuel the expansion of the market for quit-smoking medications in the future. The act of smoking involves inhaling and exhaling the vapors of burning substances like marijuana, hashish, tobacco, and others. Drugs to quit smoking are designed to decrease the desire to smoke by interfering with an individual’s craving for tobacco, and they are used as prescription medicine to manage the symptoms of nicotine withdrawal, thereby facilitating successful smoking cessation. For example, data from Statistics Canada, a Canadian government agency, revealed a 5.8% increase in cigarette production in July 2022 compared to June 2021. Furthermore, the total quantity of cigarettes sold in June 2022 rose by 1.3% from May 2022, totaling 1.4 billion. Thus, the escalating incidence of smoking addiction is spurring the growth of the market for quit-smoking drugs.

What Segmentation Categories Are Included In The Quit Smoking Drugs Market Analysis?

The quit smoking drugs market covered in this report is segmented –

1) By Product: Drug Therapy, E-Cigarettes, Nicotine Inhalers, Nicotine Replacement Therapies, Nicotine Sublingual Tablets

2) By Drug: Varenicline (Chantix), Bupropion (Zyban), Other Drugs

3) By Distribution: Drug Store, Online Pharmacies, Retail Pharmacies

Subsegments:

1) By Drug Therapy: Bupropion (Zyban), Varenicline (Chantix)

2) By E-Cigarettes: Disposable E-Cigarettes, Rechargeable E-Cigarettes, Pod Systems

3) By Nicotine Inhalers: Prescription Inhalers, Over-The-Counter Inhalers

4) By Nicotine Replacement Therapies (NRT): Nicotine Patches, Nicotine Gum, Nicotine Lozenges

5) By Nicotine Sublingual Tablets: Fast-Acting Sublingual Tablets, Extended-Release Sublingual Tablets

What Upcoming Trends Are Expected To Impact The Quit Smoking Drugs Market Globally?

Product improvisation is becoming a significant trend in acquiring a wider market share in the quit-smoking drugs domain. Leading firms in the field of quit-smoking drugs are concentrating on product innovation to consolidate their market position. As an illustration, in August 2022, a tobacco company based in Sweden, Swedish Match AB, introduced ZYN Tobacco Gold, a travel retail nicotine pouch with a tobacco flavor. Available in medium (3 mg) and strong (6 mg) strengths, Tobacco Gold caters to consumers’ preferences with its sweet tobacco taste that hints at dried fruit, wood, and caramel. Since tobacco flavor is the most favoured to assist users in choosing safer alternatives that are both devoid of tobacco and smoke-free, this product caters precisely to that demand. It presents a resolution for cigarette smokers who wish to avoid tobacco intake while still enjoying a nicotine boost in smoke-free locations.

Who Are The Top-Ranked Companies In The Quit Smoking Drugs Market Today?

Major companies operating in the quit smoking drugs market include 22nd Century Group, Cipla Limited, Dr. Reddy’s Laboratories, GSK Plc., Johnson & Johnson, NJOY LLC, Novartis AG, Perrigo Company Plc, Pfizer Inc., Philip Morris International, Glenmark Pharmaceuticals Limited, Zydus Cadila Healthcare Limited, Rusan Pharma Ltd., BioCorRx Inc., CV Sciences Inc., Ennaid Therapeutics LLC, Fertin Pharma A/S, Gilla Inc., Hikma Pharmaceuticals PLC, Innovus Pharmaceuticals Inc., IntelGenx Technologies Corp.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/quit-smoking-drugs-global-market-report

How Is Quit Smoking Drugs Market Adoption Varying Across Different Regions And Sectors?

North America was the largest region in the quit smoking drugs market in 2024. The regions covered in the quit smoking drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9247&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model